Work

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients with Relapsed/Refractory Mulitple Myeloma

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.5129.5129

Authors: Lauren Held, Jon P. Gockerman, Louis F. Diehl, Carlos Manuel de Castro, Joseph O. Moore, David A. Rizzieri, Gwynn D. Long, Mitchell E. Horwitz, Nelson J. Chao, Cristina Gasparetto

Institutions: Virginia Commonwealth University, Duke Medical Center, Duke University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2551757005

FWCI:

Cites:

Cited by:

Related to: 10